Envenoming by serpent bites in France and its treatment;Les envenimations par les serpents de France et leur traitement

Presse Medicale

Volumn 32, Issue 24, 2003, Pages 1131-1137

  De Haro, Luc ^a  

^a Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SNAKE VENOM ANTISERUM; VIPER VENOM; VIPERFAV;

CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DROWSINESS; DRUG TOLERABILITY; ENVENOMATION; MEDICAL ASSESSMENT; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; SNAKEBITE;

ANTIVENINS; FRANCE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; SNAKE BITES;

EID: 0037825990     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Goyffon M, Chippaux J.-P. Animaux venimeux terrestres. Encycl Méd Chir (Elsevier, Paris). Toxicologie Pathologie professionnelle, 16-078-A10, 1990; 14p.
2. Aubert M, de Haro L. Jouglard J. Les envenimations par les serpents exotiques. Méd Trop 1996; 56: 384-92.
3. de Haro L, Valli M. Envenimations en France métropolitaine: vipères, faune autochtone et nouveaux animaux de compagnie. Rev Prat Anesth Réanim 1999; 3: 103-9.
4. de Haro L, Lang J, Bedry R et al. Envenimations par vipères européennes. Etude multicentrique de tolérance du Viperfav*, nouvel antivenin par voie intraveineuse. Ann Fr Anesth Réanim 1998; 17: 681-7.
5. Orsini P, de Haro L, Arribas OJ, Baron JP, Ferrières R, Labeyrie A, Mossot M. Envenimation par vipère d'Orsini: 8 observations. Presse Méd 1998; 27; 1277-8.
6. Harry P, de Haro L, Asfar P, David J.-M. Evaluation de l'immunothérapie anti-vipérine par fragments F (ab')2 purifiés (ViperfavTM) par voie veineuse. Presse Méd 1999; 28: 1929-34.
7. Audebert F, Sorkine M, Bon C. Envenoming by viper bites in France: clinical gradation and biological quantification by Elisa. Toxicon 1992; 30: 599-609.
8. Jan V, Maroun RC, Robbe-Vincent A, de Haro L, Choumet V. Toxicity evolution of Vipera aspis aspis venom: identification and molecular modeling of a novel phospholipase A2 heterodimer neurotoxin. FEBS Lett 2002; 527: 263-8.
9. Audebert F, Sorkine M, Robbe-Vincent A, Bon C. Viper bites in France: clinical and biological evaluation, kinetics of envenomations. Human Exp Toxicol 1994; 13: 683-8
10. de Haro L, Hayek-Lanthois M, Jouglard JP, David JM, Jouglard J. Envenimations par serpents exotiques: bilan du Centre Anti-Poisons de Marseille. Bull Soc Herp Fr 1995; 75-76: 51-6.
11. Lachaux A, Floret D, Hartemann E, Berthier JC, Armand J.-P. Les formes mortelles d'enverimation par les vipères en France. A propos de trois observations pédiatriques. JEUR 1990; 4: 249-53.
12. Audebert F, Grosselet O, Sabouraud A, Bon C. Quantitation of venon artigens from European Vipers in human serum or urine by ELISA. J Anal Toxicol 1993; 17: 236-40.
13. de Haro L, Choumet V, Robbe A, Bon C, Jouglard J, Perringue C. Des vipères neurotoxiques dans les Alpes Maritimes? Rev Prat MG 1994; 8 (265): 20-3.
14. Stoebner PE, Cabot C, Jarry DM, Meynadier J, Meunier L. Envenimation neurotoxique par morsure de vipère. Presse Méd 2001; 30: 220.
15. Re G, Trisolino G, Miglio F. Eye muscle paralysis after Vipera aspis envenomation. J Accid Emerg Med 1999; 16: 458.
16. Beer E, Putorti F. Dysphonia, an uncommon symptom of systemic neurotoxic envenomation by Vipera aspis bite. Report of two cases. Toxicon 1998; 36: 697-701.
17. Seiberras S, Guez S, Bédry R, Seriés C. Traitement par fragment F (ab')2(Viperfav*) d'une envenimation vipérine. Presse Méd 2002; 31: 262.
18. de Haro L, Robbe-Vincent A, Saliou B, Valli M, Bon C, Choumet V. Unusual neurotoxic envenomations by Vipera aspis aspis snakes in France. Human Exp Toxicol 2002; 21: 137-45.
19. Komori Y, Nikai T, Sugihara H. Comparison of the lethal components in Vipera aspis aspis and Vipera aspis zinnikeri venom. J Nat Toxins 1998; 7: 101-8.
20. de Haro L. Intoxication par les venins. Rev Prat 2000; 50: 401-6.
21. Bon C. Serum therapy was discovered 100 years ago. In: Envenomings and their treatments. Bon C, Goyffon M. Fondation Marcel Mérieux Ed Lyon 1996; 3-9.
22. Karlson-Stiber C, Persson H, Heath A, Smith D, Al-Abdulla H, Sjöström L. First clinical experiences with specific fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming. J Intern Med 1997; 241: 53-8.
23. Audebert F, Uritzberea M, Sabouraud A, Scherrmann JM, Bon C. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits. J Pharm Ex Ther 1994; 268: 1512-7.
24. Pepin S, Lutsch C, Grandgeorge M, Sherrmann J.-M. Snake F (ab′)2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administration in rabbits. Pharmaceutical Research 1995; 12; 1470-3.
25. Rivière G, Choumet V, Audebert F et al. Effect of antivenom on venom pharmacokinetics in experimental envenomed rabbits: toward an optimization of antivenom therapy. J Pharm Ex Ther 1997; 281: 1-8.
26. Rivière G, Choumet V, Saliou B, Debray M, Bon C. Absorption and elimination of viper venom after antivenom administration. J Pharm Ex Ther 1998, 285: 490-5.
27. de Haro L, Choumet V, Robbe-Vincent A, Saliou B, Valli M, Bon C. Vipers with neurotoxic venom in southeastern France: effectiveness of the polyvalent antivenom Viperfav* for the treatment of envenomed patients. J Toxicol Clin Toxicol 1999; 37: 389-90.
28. Rosenberg HI, Kinamon S, Kochva E, Bdolah A. The secretion of Duvernoy's Gland of Malpolon monspessulanus induces haemorrhage in lungs of mice. Toxicon 1992; 30: 920-4.
29. Gonzales D. Epidemiological and clinical aspects of certain venimous animals of Spain. Toxicon 1982; 20: 925-8.
30. Kuch U, Mebs D. Envenomations by colubrid snakes in Africa, Europe and the Middle East. J Toxicol Toxin Rev 2002; 21: 159-79.
31. Bédry R, Hilbert G, Goyffon M, Laffort P, Parrens E. Is the saliva of the european whip snake (Coluber viridiflavus) neurotoxic? Toxicon 1998; 36: 1729-30.
32. Thomas L, Tyburn B, Bucher B et al. Prevention of thrombosis in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a non specific antivenom. Am J Trop Med Hyg 1995; 52: 419-26.
33. Thomas L, Tyburn B, Lang J. Tolérance et efficacité d'un fragment F (ab′)2 antivenimeux équin spécifique administré par voie intraveineuse dans le traitement des morsures de serpent (Bothrops lanceolatus) en Martinique. Réan Urg 1998, 7: 381-7.